EP2978419
Samsetningar til að bæta lífvænleika frumna og aðferðir við notkun þeirra
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
24.2.2014EP published:
15.4.2020EP application number:
14775675.3
EP translation filed:
29.4.2020Grant published:
15.5.2020EPO information:
European Patent Register
Max expiry date:
23.2.2034Expiry date:
23.2.2027Next due date:
28.2.2027
Title:
COMPOSITIONS FOR IMPROVING CELL VIABILITY AND METHODS OF USE THEREOF
Timeline
Today
24.2.2014EP application
15.4.2020EP Publication
29.4.2020Translation submitted
15.5.2020Registration published
23.2.2027Expires
Owner
Name:
Amylyx Pharmaceuticals Inc.Address:
43 Thorndike St, Cambridge, MA 02141, US
Inventor
Name:
COHEN, Joshua B.Address:
Boston, Massachusetts 02116-5760, US
Name:
KLEE, JustinAddress:
Cambridge, Massachusetts 02141, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201361804690 PDate:
24.3.2013Country:
US
Number:
201314140083Date:
24.12.2013Country:
US
Classification
Categories:
A61K 31/19, A61K 31/195, A61K 31/185, A61P 25/28, A61P 25/00, A61K 31/575, A61K 31/192
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 2.2.2021
Expires: 23.2.2022
Payer: Sigurjónsson & Thor ehf.
Number: 9
Paid: 18.2.2022
Expires: 23.2.2023
Payer: Patice ehf.
Number: 10
Paid: 31.1.2023
Expires: 23.2.2024
Payer: Árnason Faktor ehf.
Number: 10
Paid: 31.1.2023
Expires: 23.2.2024
Payer: Árnason Faktor ehf.
Number: 11
Paid: 31.1.2024
Expires: 23.2.2025
Payer: Árnason Faktor ehf.
Number: 12
Paid: 26.2.2025
Expires: 23.2.2026
Payer: Árnason Faktor ehf.
Number: 13
Paid: 5.2.2026
Expires: 23.2.2027
Payer: UAB METIDA